Azathioprine treatment of intractable pruritus: A retrospective review

Journal of the American Academy of Dermatology

Volumn 73, Issue 3, 2015, Pages 439-443

  Maley, Alexander ^a   Swerlick, Robert A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

azathioprine; corticosteroids; immunology; immunosuppression; itch; pruritus; quality of life; thioguanine

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; MYCOPHENOLATE MOFETIL; THIOPURINE METHYLTRANSFERASE; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; BASAL CELL CARCINOMA; BONE MARROW SUPPRESSION; BREAST CANCER; CHRONIC DISEASE; CHRONIC PRURITUS; DISEASE DURATION; DRESS SYNDROME; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL SYMPTOM; GENOTYPE; HAIR LOSS; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HYPERTRANSAMINASEMIA; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREATITIS; PNEUMONIA; PRIORITY JOURNAL; PRURITUS; PURINE SYNTHESIS; RETROSPECTIVE STUDY; REVIEW; SKIN CANCER; SKIN CARCINOMA; SKIN DISEASE ASSESSMENT; SKIN INFECTION; SQUAMOUS CELL CARCINOMA; STAPHYLOCOCCUS INFECTION; SUPERINFECTION; TONGUE CARCINOMA; TREATMENT DURATION; VISUAL ANALOG SCALE; VISUAL ANALOG SCALE ITCH SCORE; COHORT ANALYSIS; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; MIDDLE AGED; RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; AGED; AZATHIOPRINE; CHRONIC DISEASE; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PRURITUS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84939466121     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2015.05.025     Document Type: Article

References (16)

1. R. Paus, M. Schmelz, T. Bíró, and M. Steinhoff Frontiers in pruritus research: scratching the brain for more effective itch therapy J Clin Invest 116 2006 1174 1186
2. A.A. Patel, R.A. Swerlick, and C.O. McCall Azathioprine in dermatology: the past, the present, and the future J Am Acad Dermatol 55 2006 369 389
3. M.E. Cotes, and R.A. Swerlick Practical guidelines for the use of steroid-sparing agents in the treatment of chronic pruritus Dermatol Ther 26 2013 120 134
4. M. Steinhoff, F. Cevikbas, A. Ikoma, and T.G. Berger Pruritus: management algorithms and experimental therapies Semin Cutan Med Surg 30 2011 127 137
5. C. Cuffari, S. Hunt, and T. Bayless Utilization of erythrocyte 6-thioguanine metabolite levels to optimize azathioprine therapy in patients with inflammatory bowel disease Gut 48 2001 642 646
6. S.F. Thomsen, T. Karlsmark, K.K. Clemmensen, and et al. Outcome of treatment with azathioprine in severe atopic dermatitis: a 5-year retrospective study of adult outpatients Br J Dermatol 172 2015 1122 1124
7. S.J. Meggitt, J.C. Gray, and N.J. Reynolds Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomized controlled trial Lancet 367 2006 839 846
8. J. Berth-Jones, A. Takwale, E. Tan, and et al. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial Br J Dermatol 147 2002 324 330
9. R. Hughes, P. Collins, and S. Rogers Further experience of using azathioprine in the treatment of severe atopic dermatitis Clin Exp Dermatol 33 2008 710 711
10. N. Khan, A.M. Abbas, G.R. Lichtenstein, E.V. Loftus Jr., and L.A. Bazzano Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study Gastroenterology 145 2013 1007 1015
11. B. Pasternak, H. Svanström, K. Schmiegelow, T. Jess, and A. Hviid Use of azathioprine and the risk of cancer in inflammatory bowel disease Am J Epidemiol 177 2013 1296 1305
12. A. Kandiel, A.G. Fraser, B.I. Korelitz, C. Brensinger, and J.D. Lewis Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine Gut 54 2005 1121 1125
13. J.M. van den Reek, P.P. van Lümig, M. Janssen, and et al. Increased incidence of squamous cell carcinoma of the skin after long-term treatment with azathioprine in patients with auto-immune inflammatory rheumatic diseases J Eur Acad Dermatol Venereol 28 2014 27 33
14. W.W. Bottomley, G. Ford, W.J. Cunliffe, and J.A. Cotterill Aggressive squamous cell carcinomas developing in patients receiving long-term azathioprine Br J Dermatol 133 1995 460 462
15. J. Ariyaratnam, and V. Subramanian Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis Am J Gastroenterol 109 2014 163 169
16. R.M. Weinshilboum, and S.L. Sladek Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity Am J Hum Genet 32 1980 651 662